Athira Pharma Inc
Change company Symbol lookup
Select an option...
ATHA Athira Pharma Inc
FAZE FaZe Holdings Inc
AYTU Aytu Biopharma Inc
WFC Wells Fargo & Co
XOM Exxon Mobil Corp
URBF Urban Barns Foods Inc
ETO Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
FMS Fresenius Medical Care AG & Co KGaA
JNJ Johnson & Johnson
MYTE MYT Netherlands Parent BV
Go

Health Care : Pharmaceuticals |
Company profile

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company's lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, blood brain barrier (BBB)-penetrating, small molecule HGF/MET positive modulator. The primary target indication is Alzheimers disease. The ATH-1017, is a subcutaneous administered, BBB-penetrating, small molecule hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) activator for the treatment of neurodegenerative disorders, with an initial focus on Alzheimer's disease (AD). It also has preclinical candidates for non-AD indications, including ATH-1018, which is being developed to address peripheral indications, and ATH-1019/ATH-1020 compounds, which are being advanced to address neuropsychiatric indications. ATH technology is designed to promote HGF/MET activity for a variety of clinical applications.

Postmarket

Last Trade
Delayed
$3.02
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.02
Day's Change
-0.14 (-4.43%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
3.15
Day's Low
2.99
Volume
(Average)
Volume:
230,037

10-day average volume:
248,114
230,037
  • Prev Close
    3.16
  • Today's Open
    3.14
  • Day's Range
    2.99-3.15
  • Avg Vol (10-day)
    248.1K
  • Last (time)
    4:00p ET 10/07/22
  • Last (size)
    104
  • 52-Wk Range
    2.53 - 16.65
    LowHigh
  • (11/12/21 - 06/22/22)
    19.37%
  • 125.0%
  • Market Cap
    114.2M
  • Shares Outstanding
    37.8M
  • -1.99
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 59.92
  • (% of float 09/15/22)
    5.98

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.